Dr. Evita B. Henderson-Jackson, MD

Dr. Henderson-Jackson practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Dr. Henderson-Jackson's NPI, 1578752598, was assigned on October 16, 2007. Dr. Henderson-Jackson graduated from School of Medicine Columbia in 2006. Dr. Henderson-Jackson holds Florida license ME104658.

Dr. Henderson-Jackson's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Dr. Henderson-Jackson's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Henderson-Jackson is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Henderson-Jackson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Henderson-Jackson practices, 3 sites in all. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Henderson-Jackson's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Henderson-Jackson is board certified in cytopathology by the American Board of Pathology. Dr. Henderson-Jackson is licensed in Florida.

CMS data shows 1,679 Medicare services from Dr. Henderson-Jackson across 11 procedure codes in 2024, for 375 Medicare patients. Medicare paid $48,385 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 375 Medicare patients who saw Dr. Henderson-Jackson in 2024. The largest group is 65 to 74, with 182 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Henderson-Jackson's median patient age at 66, with 52% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Henderson-Jackson for performance year 2024, reported as part of a group. Dr. Henderson-Jackson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 36 papers to Dr. Henderson-Jackson, published from 2010 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Immunohistochemistry, Sarcoma and Soft Tissue Neoplasms. Dr. Henderson-Jackson has published most often in Radiol Case Rep. Dr. Henderson-Jackson's most frequent co-authors are Marilyn Yuanxin Ma Bui, MD, Domenico Coppola, MD and Andrew S. Brohl, MD.

CMS Open Payments shows 1 general payment to Dr. Henderson-Jackson from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Roche Diagnostics Corporation paid the most, $87.

Dr. Henderson-Jackson graduated from School of Medicine Columbia in 2006.

Dr. Henderson-Jackson is in network with 2 carriers, including Excellus BlueCross BlueShield and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.